We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleNSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.AuthorsGalipeau PC; Li X; Blount PL; Maley CC; Sanchez CA; Odze RD; Ayub K; Rabinovitch PS; Vaughan TL; Reid BJPublicationPLoS medicine, 2007, Vol 4, Issue 2, pe67ISSN1549-1676Publication typearticleDOI10.1371/journal.pmed.0040067